Revenio Group Corporation’s Leadership team member Tomi Karvo (Vice President, Products, Brand and Marketing), responsible for iCare products, brand and marketing has decided to take on new challenges outside the company. As of March 1, 2024, he will be succeeded by Director Erkki Tala who is currently working on the development of Revenio's strategy process and business planning. Tomi is committed to supporting Erkki in the smooth handover of his tasks.
"I want to thank Tomi for his remarkable, nearly 9-year career at the Revenio Group. His contribution to the development of iCare's commercial operations has been significant. I wish Tomi best of success in his future endeavors. At the same time, I am extremely pleased that there is a strong successor from within the organization to continue the excellent work done by Tomi", thanks Jouni Toijala, CEO of Revenio Group.
B.Sc Optometry Erkki Tala (b. 1977) is an experienced business leader and a professional in eye health-related business. He has more than 20 years of experience working in demanding leadership and business development positions in the optical industry at Specsavers and Grand Vision group company Instru Optiikka. Erkki has solid expertise, especially in development projects creating new business opportunities, including the digitization of traditional service models and the creation of new service concepts. He has been working in the Revenio Group since June 2023.
"Erkki's experience in the industry from the perspective of international business development is a significant strength for us in implementing our growth strategy. His role is central as we move towards integrated and predictive eye care pathways and expand into new segments, particularly in AI-assisted eye health screening and monitoring. I warmly welcome Erkki to the Leadership team of Revenio Group in his new role as the Vice President responsible for iCare's products, brand, and marketing", continues Jouni Toijala.
“Revenio is a great company with strong knowledge and expertise in ophthalmic diagnostics. I’m excited about the opportunity to join company’s skilled and professional Leadership team. In the current phase of our business, I believe that my extensive experience from eye care market, creating and implementing different service concepts as well as building smart care pathways will help us together continue to drive sustainable and profitable growth according to our strategy”, says Erkki Tala.
Composition and responsibilities of the Revenio Group Leadership team as of March 1, 2024:
• Jouni Toijala, CEO
• John Floyd, Vice President, Sales
• Heli Huopaniemi, Vice President, Quality
• Ari Isomäki, Vice President, Operations
• Robin Pulkkinen, CFO
• Marco Rizzardo, Vice President, R&D
• Erkki Tala, Vice President, Products, Brand and Marketing
• Kate Taylor, Vice President, Strategy and Business Development
• Hanna Vuornos, Vice President, People and Culture
Revenio Group Corporation
Board of Directors
For further information, please contact
Jouni Toijala, President & CEO, tel. +358 50 484 0085
jouni.toijala@revenio.fi
Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Principal media
www.reveniogroup.fi/en/
Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
In 2022, the Group’s net sales totaled EUR 97.0 million, with an operating profit of EUR 29.7 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
REVENIO GROUP OYJ 
